Label-free Detection Market by Product & Service (Instruments, Consumables (Biosensor Chip), Software), Technology (Surface Plasmon Resonance), Application (Binding Kinetics), End User (Pharmaceutical & Biotechnology Companies) - Global Forecast to 2025
[193 Pages Report] The global label-free detection market size is estimated to be USD 431 million in 2020 and projected to reach USD 626 million by 2025, at a CAGR of 7.7%. Growth in this market is largely driven by the introduction of technologically advanced products, a growing number of drug discovery programs through academic-industrial partnerships, and the high sensitivity of label-free technologies.
To know about the assumptions considered Request for Free Sample Report
COVID-19 impact on the global label-free detection market
According to researchers based in ETH Zurich (Switzerland) Localized Surface Plasmon Resonance (LSPR) demonstrated a high degree of accuracy and sensitivity when tasked with detecting COVID-19 RNA. Surface Plasmon Resonance is one of the major technologies used in label-free detection. This is a major indicator of market growth. In addition to this, label-free products such as SPR systems and biosensors are also being used for COVID-19 research. However, R&D labs are now operating below 50% of the normal capacity. According to an analysis of studies based on ClinicalTrials.gov, among the 2522 clinical trial registry entries that were suspended, terminated, or withdrawn between December 1, 2019, and May 5, 2020, around 44% were closed with a reported reason that explicitly mentioned COVID-19. These factors could hinder the growth of the market.
Label-Free Detection Market Dynamics
Driver: Introduction of technologically advanced products
Relatively new in the well-established field of high-throughput screening (HTS), label-free technologies provide opportunities for probing biomolecular interactions without spatial interference or the auto-fluorescent or quenching effects of labels.
On average, it takes at least ten years for a new drug to complete the journey from initial discovery to the marketplace. The average cost of research & development for each successful drug is estimated to be USD 2.6 billion (PhRMA). With escalating cost pressures and increasingly complex disease targets, improving productivity in early drug discovery processes has been a challenge.
Initially, low throughput was a major challenge associated with label-free technologies. However, the introduction of SPR-based label-free systems with higher throughput has helped increase overall operational efficiency while providing the high-quality data needed to make informed decisions.
Some other examples of technologically advanced products launched in recent years include:
- The latest innovation in differential scanning calorimetry (DSC) from Spectris (UK) has been created specifically for regulated environments and delivers essential data to guide biopharmaceutical development. In 2017, the company introduced the MicroCal PEAQ-DSC microcalorimeter, which delivers unattended 24-hour operations, together with streamlined workflows and automated data analysis, to produce results in hours, driving productivity and efficiency gains in research and production.
- In 2018, Danaher (US) introduced Biacore 8K+, an eight-needle, high-sensitivity surface plasmon resonance (SPR) system that enables the automation of over 4,500 drug candidate–disease target binding experiments in one run. It can be paired with the Biacore Insight Evaluation Software to translate high-quality data into actionable insights.
- In 2019, Agilent Technologies (US) introduced a first-of-its-kind multimode real-time cell analyzer (RTCA), which combines the best of non-invasive biosensor measurements with live-cell imaging. Such advancements provide label-free, real-time biosensor measurements and kinetic imaging of the same live cell populations, independently or simultaneously. This will revolutionize cell analysis in life science research.
- In 2020, Nicoya (Canada) launched Alto, which is a fully automated, high-throughput benchtop SPR system. It uses digital microfluidics (DMF), which removes the need for any physical pumps, valves, or tubes, and replaces them with low-cost disposable cartridges. This, in turn, reduces the time and cost of drug discovery, enabling scientists to better understand and cure human diseases faster.
These technological advancements have increased the adoption of label-free technologies by pharmaceutical and biopharmaceutical companies as well as academic research institutes for biomolecular analysis during drug discovery. This is expected to drive market growth.
Restraint: High cost of instruments
Label-free detection instruments are highly expensive since they are equipped with advanced features and functionalities. A typical Bio-layer interferometry system ranges from about USD 50,000 to USD 300,000. Agilent’s (US) xCELLigence systems are offered for both academia and the industrial sector, and they cost USD 50,000 to USD 500,000, depending on options such as throughput. Companies with smaller R&D budgets cannot afford these instruments, which is a major factor limiting market growth. Academic research laboratories also find it difficult to invest in these instruments due to budget constraints. In addition to this, the high capital and running costs, as well as weekly maintenance costs of SPR systems, have restricted label-free platforms to well-funded labs and academic core labs. SPR platforms are also complex to run, making them unsuitable for multi-user laboratories.
On the other hand, pharmaceutical companies are the biggest end users of LFD instruments and have relatively larger R&D budgets; however, their requirement for many such instruments drives up their capital expenditure. Thus, the high cost of LFD instruments could limit the demand for these instruments, which, in turn, may restrict the overall market growth.
Opportunity: Growing life science research activities in emerging markets
Growth in the Asian economies, particularly China and India, along with increased investments in biotechnology and drug discovery, are the major factors driving the label-free detection market in Asia. Currently, most Asian countries do not possess established business models but have the scientific talent to develop strong local biotechnology industries. Hence, the number of mergers, collaborations, and partnerships are on the rise in these emerging countries. Many Asian economies have modified regulations, policies, and guidelines to support investments, innovation, and commercialization. Owing to this, research activities in the life science industry are on the rise.
Over the years, China’s pharma industry has moved from a primary focus on generics manufacturing and copy-cat drugs to research & development of innovative treatments. Many pharma and biopharmaceutical companies, such as AstraZeneca, GlaxoSmithKline, Sanofi, and Ferring Pharmaceuticals, have announced plans to invest in life science R&D activities in the emerging markets in the coming years. These increasing investments in the emerging markets will further boost research & development activities, which, in turn, will provide a range of growth opportunities for players in the market.
- In July 2018, Ferring Pharmaceuticals (Switzerland) laid the foundation for its R&D laboratory and manufacturing facility at Genome Valley, Hyderabad, India. The new facility added to the group’s global R&D capabilities and will be conducting novel research for emerging healthcare challenges around the world.
- In July 2018, global biopharmaceutical company Sanofi (France) announced plans to establish a global research & development operations hub in Chengdu, China. Sanofi plans to use the hub to tackle therapeutic areas, including vaccines, immunology and inflammation, and cardiovascular diseases.
- In November 2019, AstraZeneca (UK) announced large-scale initiatives in China to advance global medicine research & development. The initiative includes the creation of a new global R&D center and an artificial intelligence (AI) innovation center in Shanghai, China.
Label-free detection technologies deliver revolutionary efficiency improvements for life science research applications. Hence, such increasing life science research activities in the emerging markets will accelerate the growth of the label-free detection market in these countries.
Challenge: Shortage of skilled professionals
Label-free detection is a relatively new technology that requires experts with a wide range of skill sets and good knowledge of instrument and software handling. Many of the highly automated, high-throughput platforms require skilled personnel to set up and run a label-free experiment. In research laboratories and companies, there is a high demand for researchers who are well-versed in handling label-free detection instruments.
However, at present, there is a shortage of such professionals, forcing most companies to opt for conventional methods such as cell-based assays and fluorescence- and radioactive-labeled instruments. This poses a challenge to the label-free detection market
By consumables segment, the biosensor chips segment accounted for the largest share of the the label-free detection market in 2019.
On the basis of product & service type, the consumables market is segmented into biosensor chips, microplates and reagents & kits. In 2019, biosensor chips accounted for the largest share of the consumables segment mainly due to the high specificity and ability to monitor molecular interactions in real-time.
By technology, the surface plasmon resonance segment accounted for the largest share of the label-free detection market in 2019.
On the basisi of technology, the market is categorized into five technology segments—surface plasmon resonance, bio-layer interferometry, differential scanning calorimetry, isothermal titration calorimetry, and other label-free detection technologies. The surface plasmon resonance segment accounted for the largest share in 2019, due to the high sensitivity of this technology and its wide usage in determining specificity, affinity, and kinetic parameters during the binding of macromolecules.
By end user, pharmaceutical & biotechnology companies segment accounted for the largest share of label-free detection market in 2019.
On the basis of end user, the label-free detection market has been segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations (CROs), and other end users such as food & beverage, agriculture and livestock, oil & gas, environmental monitoring, chemicals, bioplastics, and cosmeceuticals. The pharmaceutical & biotechnology companies segment dominated the label-free detection market in 2019, owing to the extensive use of label-free detection technologies by pharmaceutical & biotechnology companies for studying biomolecular interactions in drug discovery.
North America accounted for the largest share of the label-free detection market in 2019.
In 2019, North America accounted for the largest share of the overall market, followed by Europe. The availability of funds for research, increasing research activities in drug discovery and development, growth in pharmaceutical R&D spending, and the presence of key players are the major factors driving the North American market.
To know about the assumptions considered for the study, download the pdf brochure
Key Market Players
The label-free detection market is dominated by a few globally established players such as Danaher (US), Sartorius (Germany), Waters Corporation (US), PerkinElmer (US), AMETEK (US), HORIBA (Japan), Spectris (UK), METTLER TOLEDO (US), Corning (US), and Agilent Technologies (US).
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market Size Available for Years |
2018–2025 |
|
Base Year Considered |
2019 |
|
Forecast Period |
2020–2025 |
|
Forecast Units |
Value (USD) |
|
Segments Covered |
Product & Service, Technology, Application, End User, and Region |
|
Geographies Covered |
North America, Europe, APAC and the RoW |
|
Companies Covered |
The major market players include Danaher (US), Sartorius AG (Germany), Waters Corporation (US), PerkinElmer Inc. (US), AMETEK, Inc. (US), HORIBA Ltd. (Japan), Spectris (UK), METTLER TOLEDO (US), Corning Incorporated (US), and Agilent Technologies, Inc. (US) (Total 25 companies)
|
The study categorizes the label free detection market into the following segments and subsegments:
Label-free detection Market, by Product & Service
- Instruments
- Consumables
- Biosensor Chips
- Microplates
- Reagents & Kits
- Software & Services
Label-free detection Market, by Technology
- Surface Plasmon Resonance
- Bio-layer Interferometry
- Isothermal Titration Calorimetry
- Differential Scanning Calorimetry
- Other LFD Technologies
Label-free detection Market by Application
- Binding Kinetics
- Hit Confirmation
- Lead Generation
- Endogenous Receptor Detection
- Binding Thermodynamics
- Other Applications
Label-free detection Market, by End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Other End Users
Label-free detection Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Rest of the World
- Latin America
- The Middle East and Africa
Recent Developments
- In 2020, Danaher acquired the Biopharma business from General Electric Company's Life Sciences division. The business will be known as Cytiva and will act as a standalone operating company within Danaher's Life Sciences segment.
- In 2020, Sartorius acquired selected life science businesses of Danaher Corporation. This acquisition includes the ForteBio business of Danaher and it will be integrated into the Bioanalytics unit within the Sartorius Lab Products & Services division.
- In 2020, Malvern Panalytical (a division of Spectris) opened a new APAC Application Center of Excellence in Shanghai, China. The center showcases a large part of the Malvern Panalytical technology portfolio including Differential Scanning Calorimetry (DSC) and Isothermal Titration Calorimetry (ITC) technology.
- In 2020, TA Instruments (a subsidiary of Waters) entered into a partnership with Gulf Bio Analytical. Under the terms of this partnership, TA Instruments appointed Gulf Bio Analytical as its exclusive distributor of instruments in Saudi Arabia.
- In 2020, Creoptix collaborated with Professor Adriano Aguzzi and the University of Zurich to characterize anti-SARS-CoV-2 Antibodies in patients with the COVID-19 using the Creoptix WAVE system.
Frequently Asked Questions (FAQ):
What is the current size of the global label-free detection market?
The global label-free detection market size is estimated to be USD 431.7 million in 2020 and projected to reach USD 626.4 million by 2025, at a CAGR of 7.7%.
Who are the leading players in the label-free detection market?
Some of the leading players in the label-free detection market include Danaher (US), Sartorius AG (Germany), Waters Corporation (US), PerkinElmer Inc. (US), AMETEK, Inc. (US), HORIBA Ltd. (Japan), Spectris (UK), METTLER TOLEDO (US), Corning Incorporated (US), and Agilent Technologies, Inc. (US).
Who are the major end users of the label-free detection market?
The end users of the label-free detection market are pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations (CROs), and other end users such as food & beverage, agriculture and livestock, oil & gas, environmental monitoring, chemicals, bioplastics, and cosmeceuticals. The pharmaceutical & biotechnology companies segment are the largest end users in the label-free detection market due to the extensive use of label-free detection technologies by pharmaceutical & biotechnology companies for studying biomolecular interactions in drug discovery.
What are the major drivers of the label-free detection market?
Some of the major drivers of the label-free detection market include the introduction of technologically advanced products, a growing number of drug discovery programs through academic-industrial partnerships, and the high sensitivity of label-free technologies.
What is the COVID-19 impact on the label-free detection market?
According to researchers based in ETH Zurich (Switzerland) Localized Surface Plasmon Resonance (LSPR) demonstrated a high degree of accuracy and sensitivity when tasked with detecting COVID-19 RNA. Surface Plasmon Resonance is one of the major technologies used in label-free detection. This is a major indicator of market growth. In addition to this, label-free products such as SPR systems and biosensors are also being used for COVID-19 research. However, R&D labs are now operating below 50% of the normal capacity. According to an analysis of studies based on ClinicalTrials.gov, among the 2522 clinical trial registry entries that were suspended, terminated, or withdrawn between December 1, 2019, and May 5, 2020, around 44% were closed with a reported reason that explicitly mentioned COVID-19. These factors could hinder the growth of the market. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 29)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 34)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET DATA ESTIMATION & TRIANGULATION
2.2.1 DATA TRIANGULATION
FIGURE 1 DATA TRIANGULATION METHODOLOGY
2.3 MARKET ESTIMATION METHODOLOGY
FIGURE 2 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
FIGURE 3 LABEL-FREE DETECTION MARKET SIZE (USD BILLION)
FIGURE 4 LABEL-FREE DETECTION MARKET: FINAL CAGR PROJECTIONS (2020?2025)
FIGURE 5 LABEL-FREE DETECTION MARKET: CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES
2.4 INDUSTRY INSIGHTS
2.5 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY (Page No. - 40)
FIGURE 6 LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
FIGURE 7 LABEL-FREE DETECTION MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 8 LABEL-FREE DETECTION MARKET, BY END USER, 2020?2025
FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE LABEL-FREE DETECTION MARKET
4 PREMIUM INSIGHTS (Page No. - 43)
4.1 LABEL-FREE DETECTION MARKET OVERVIEW
FIGURE 10 GROWING NUMBER OF DRUG DISCOVERY PROGRAMS TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY END USER & COUNTRY (2019)
FIGURE 11 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2019
4.3 LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE
FIGURE 12 BIOSENSOR CHIPS SEGMENT IS PROJECTED TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 45)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 13 LABEL-FREE DETECTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES, AND TRENDS
5.2.1 DRIVERS
5.2.1.1 Introduction of technologically advanced products
5.2.1.2 Growing number of drug discovery programs through academic-industrial partnerships
5.2.1.3 High sensitivity of label-free technologies
5.2.2 RESTRAINTS
5.2.2.1 High cost of instruments
5.2.3 OPPORTUNITIES
5.2.3.1 Growing life science research activities in emerging markets
5.2.4 CHALLENGES
5.2.4.1 Shortage of skilled professionals
5.2.5 TRENDS
5.2.5.1 Rising pharmaceutical outsourcing
5.2.5.2 Impact of the COVID-19 outbreak on the label-free detection market
5.3 TECHNOLOGICAL ANALYSIS
TABLE 1 TECHNOLOGY ANALYSIS: BIOSENSOR ASSAYS VS. ISOTHERMAL TITRATION CALORIMETRY
6 LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE (Page No. - 52)
6.1 INTRODUCTION
TABLE 2 LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
6.2 INSTRUMENTS
6.2.1 TECHNOLOGICAL ADVANCEMENTS IN LABEL-FREE DETECTION SYSTEMS TO DRIVE THE INSTRUMENTS MARKET
TABLE 3 LABEL-FREE DETECTION INSTRUMENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
TABLE 4 NORTH AMERICA: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 5 EUROPE: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 6 APAC: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
6.3 CONSUMABLES
TABLE 7 LABEL-FREE DETECTION CONSUMABLES MARKET, BY REGION, 2018-2025 (USD MILLION)
TABLE 8 NORTH AMERICA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 9 EUROPE: LABEL-FREE DETECTION CONSUMABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 10 APAC: LABEL-FREE DETECTION CONSUMABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 11 LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.3.1 BIOSENSOR CHIPS
6.3.1.1 Label-free biosensor chips are highly specific and allow real-time monitoring of molecular interactions
TABLE 12 LABEL-FREE DETECTION CONSUMABLES MARKET FOR BIOSENSOR CHIPS, BY REGION, 2018-2025 (USD MILLION)
TABLE 13 NORTH AMERICA: LABEL-FREE DETECTION CONSUMABLES MARKET FOR BIOSENSOR CHIPS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 14 EUROPE: LABEL-FREE DETECTION CONSUMABLES MARKET FOR BIOSENSOR CHIPS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 15 APAC: LABEL-FREE DETECTION CONSUMABLES MARKET FOR BIOSENSOR CHIPS, BY COUNTRY, 2018-2025 (USD MILLION)
6.3.2 MICROPLATES
6.3.2.1 Many research laboratories and academic institutes use microplates due to their low cost
TABLE 16 LABEL-FREE DETECTION CONSUMABLES MARKET FOR MICROPLATES, BY REGION, 2018-2025 (USD MILLION)
TABLE 17 NORTH AMERICA: LABEL-FREE DETECTION CONSUMABLES MARKET FOR MICROPLATES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 18 EUROPE: LABEL-FREE DETECTION CONSUMABLES MARKET FOR MICROPLATES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 19 APAC: LABEL-FREE DETECTION CONSUMABLES MARKET FOR MICROPLATES, BY COUNTRY, 2018-2025 (USD MILLION)
6.3.3 REAGENTS AND KITS
6.3.3.1 Availability of ready-to-use kits for assay development drives the market growth
TABLE 20 LABEL-FREE DETECTION CONSUMABLES MARKET FOR REAGENTS & KITS, BY REGION, 2018-2025 (USD MILLION)
TABLE 21 NORTH AMERICA: LABEL-FREE DETECTION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 22 EUROPE: LABEL-FREE DETECTION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 23 APAC: LABEL-FREE DETECTION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2018-2025 (USD MILLION)
6.4 SOFTWARE AND SERVICES
TABLE 24 LABEL-FREE DETECTION SOFTWARE & SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
TABLE 25 NORTH AMERICA: LABEL-FREE DETECTION SOFTWARE & SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 26 EUROPE: LABEL-FREE DETECTION SOFTWARE & SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 27 APAC: LABEL-FREE DETECTION SOFTWARE & SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
7 LABEL-FREE DETECTION MARKET, BY TECHNOLOGY (Page No. - 65)
7.1 INTRODUCTION
TABLE 28 LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
7.2 SURFACE PLASMON RESONANCE
7.2.1 GROWING USE OF SPR TECHNOLOGY IN AFFINITY AND KINETIC STUDIES TO FUEL MARKET GROWTH
TABLE 29 LABEL-FREE DETECTION MARKET FOR SURFACE PLASMON RESONANCE TECHNOLOGY, BY REGION, 2018-2025 (USD MILLION)
TABLE 30 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR SURFACE PLASMON RESONANCE TECHNOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 31 EUROPE: LABEL-FREE DETECTION MARKET FOR SURFACE PLASMON RESONANCE TECHNOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 32 APAC: LABEL-FREE DETECTION MARKET FOR SURFACE PLASMON RESONANCE TECHNOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
7.3 DIFFERENTIAL SCANNING CALORIMETRY
7.3.1 DSC IS WIDELY USED IN DRUG DISCOVERY AND DEVELOPMENT FOR THE CHARACTERIZATION OF PROTEINS
TABLE 33 LABEL-FREE DETECTION MARKET FOR DIFFERENTIAL SCANNING CALORIMETRY TECHNOLOGY, BY REGION, 2018-2025 (USD MILLION)
TABLE 34 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR DIFFERENTIAL SCANNING CALORIMETRY TECHNOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 35 EUROPE: LABEL-FREE DETECTION MARKET FOR DIFFERENTIAL SCANNING CALORIMETRY TECHNOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 36 APAC: LABEL-FREE DETECTION MARKET FOR DIFFERENTIAL SCANNING CALORIMETRY TECHNOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
7.4 BIO-LAYER INTERFEROMETRY
7.4.1 MICROFLUIDICS-FREE NATURE OF BLI TO DRIVE THE MARKET GROWTH
TABLE 37 LABEL-FREE DETECTION MARKET FOR BIO-LAYER INTERFEROMETRY TECHNOLOGY, BY REGION, 2018-2025 (USD MILLION)
TABLE 38 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR BIO-LAYER INTERFEROMETRY TECHNOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 39 EUROPE: LABEL-FREE DETECTION MARKET FOR BIO-LAYER INTERFEROMETRY TECHNOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 40 APAC: LABEL-FREE DETECTION MARKET FOR BIO-LAYER INTERFEROMETRY TECHNOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
7.5 ISOTHERMAL TITRATION CALORIMETRY
7.5.1 ISOTHERMAL TITRATION CALORIMETRY IS USED IN THE LABEL-FREE MEASUREMENT OF THE BINDING AFFINITY AND THERMODYNAMICS OF BIOMOLECULAR INTERACTIONS
TABLE 41 LABEL-FREE DETECTION MARKET FOR ISOTHERMAL TITRATION CALORIMETRY TECHNOLOGY, BY REGION, 2018-2025 (USD MILLION)
TABLE 42 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR ISOTHERMAL TITRATION CALORIMETRY TECHNOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 43 EUROPE: LABEL-FREE DETECTION MARKET FOR ISOTHERMAL TITRATION CALORIMETRY TECHNOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 44 APAC: LABEL-FREE DETECTION MARKET FOR ISOTHERMAL TITRATION CALORIMETRY TECHNOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
7.6 OTHER LFD TECHNOLOGIES
TABLE 45 LABEL-FREE DETECTION MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2018-2025 (USD MILLION)
TABLE 46 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 47 EUROPE: LABEL-FREE DETECTION MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 48 APAC: LABEL-FREE DETECTION MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018-2025 (USD MILLION)
8 LABEL-FREE DETECTION MARKET, BY APPLICATION (Page No. - 76)
8.1 INTRODUCTION
TABLE 49 LABEL-FREE DETECTION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
8.2 BINDING KINETICS
8.2.1 BINDING KINETICS HELD THE LARGEST SHARE OF THE LABEL-FREE DETECTION MARKET IN 2019
TABLE 50 LABEL-FREE DETECTION MARKET FOR BINDING KINETIC APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
TABLE 51 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR BINDING KINETIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 52 EUROPE: LABEL-FREE DETECTION MARKET FOR BINDING KINETIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 53 APAC: LABEL-FREE DETECTION MARKET FOR BINDING KINETIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
8.3 BINDING THERMODYNAMICS
8.3.1 THERMODYNAMIC STUDIES ARE WIDELY USED IN BASIC RESEARCH TO DETERMINE THE MECHANISM OF ACTION OF DRUGS
TABLE 54 LABEL-FREE DETECTION MARKET FOR BINDING THERMODYNAMIC APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
TABLE 55 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR BINDING THERMODYNAMIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 56 EUROPE: LABEL-FREE DETECTION MARKET FOR BINDING THERMODYNAMIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 57 APAC: LABEL-FREE DETECTION MARKET FOR BINDING THERMODYNAMIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
8.4 HIT CONFIRMATION
8.4.1 LABEL-FREE TECHNOLOGIES ALLOW THE STUDY OF BIOMOLECULAR INTERACTIONS IN THEIR NATIVE STATES
TABLE 58 LABEL-FREE DETECTION MARKET FOR HIT CONFIRMATION APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
TABLE 59 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR HIT CONFIRMATION APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 60 EUROPE: LABEL-FREE DETECTION MARKET FOR HIT CONFIRMATION APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 61 APAC: LABEL-FREE DETECTION MARKET FOR HIT CONFIRMATION APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
8.5 LEAD GENERATION
8.5.1 LABEL-FREE TECHNOLOGIES PROVIDE GREATER DEPTH OF INFORMATION IN THE DRUG CANDIDATE SELECTION PROCESS
TABLE 62 LABEL-FREE DETECTION MARKET FOR LEAD GENERATION APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
TABLE 63 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR LEAD GENERATION APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 64 EUROPE: LABEL-FREE DETECTION MARKET FOR LEAD GENERATION APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 65 APAC: LABEL-FREE DETECTION MARKET FOR LEAD GENERATION APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
8.6 ENDOGENOUS RECEPTOR DETECTION
8.6.1 HIGH SENSITIVITY OF LABEL-FREE ASSAYS DRIVING THEIR USE FOR DETECTING ENDOGENOUS RECEPTORS
TABLE 66 LABEL-FREE DETECTION MARKET FOR ENDOGENOUS RECEPTOR DETECTION APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
TABLE 67 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR ENDOGENOUS RECEPTOR DETECTION APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 68 EUROPE: LABEL-FREE DETECTION MARKET FOR ENDOGENOUS RECEPTOR DETECTION APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 69 APAC: LABEL-FREE DETECTION MARKET FOR ENDOGENOUS RECEPTOR DETECTION APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
8.7 OTHER APPLICATIONS
TABLE 70 LABEL-FREE DETECTION MARKET FOR OTHER APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
TABLE 71 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 72 EUROPE: LABEL-FREE DETECTION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 73 APAC: LABEL-FREE DETECTION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
9 LABEL-FREE DETECTION MARKET, BY END USER (Page No. - 89)
9.1 INTRODUCTION
TABLE 74 LABEL-FREE DETECTION MARKET, BY END USER, 2018-2025 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 GROWING ADOPTION OF LABEL-FREE DETECTION TECHNOLOGIES BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES FOR STUDYING MOLECULAR INTERACTIONS TO FUEL MARKET GROWTH
TABLE 75 LABEL-FREE DETECTION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
TABLE 76 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 77 EUROPE: LABEL-FREE DETECTION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 78 APAC: LABEL-FREE DETECTION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
9.3 ACADEMIC & RESEARCH INSTITUTES
9.3.1 RISING INDUSTRY-ACADEMIA COLLABORATIONS FOR RESEARCH TO DRIVE THE GROWTH OF THIS MARKET
TABLE 79 LABEL-FREE DETECTION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION)
TABLE 80 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 81 EUROPE: LABEL-FREE DETECTION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 82 APAC: LABEL-FREE DETECTION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
9.4 CONTRACT RESEARCH ORGANIZATIONS
9.4.1 INCREASING PHARMACEUTICAL OUTSOURCING TO DRIVE MARKET GROWTH
TABLE 83 LABEL-FREE DETECTION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2025 (USD MILLION)
TABLE 84 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 85 EUROPE: LABEL-FREE DETECTION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 86 APAC: LABEL-FREE DETECTION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
9.5 OTHER END USERS
TABLE 87 LABEL-FREE DETECTION MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION)
TABLE 88 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR OTHER END USERS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 89 EUROPE: LABEL-FREE DETECTION MARKET FOR OTHER END USERS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 90 APAC: LABEL-FREE DETECTION MARKET FOR OTHER END USERS, BY COUNTRY, 2018-2025 (USD MILLION)
10 LABEL-FREE DETECTION MARKET, BY REGION (Page No. - 98)
10.1 INTRODUCTION
TABLE 91 LABEL-FREE DETECTION MARKET, BY REGION, 2018-2025 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 14 NORTH AMERICA: LABEL-FREE DETECTION MARKET SNAPSHOT
TABLE 92 NORTH AMERICA: LABEL-FREE DETECTION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 93 NORTH AMERICA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 94 NORTH AMERICA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 95 NORTH AMERICA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 96 NORTH AMERICA: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 97 NORTH AMERICA: LABEL-FREE DETECTION MARKET, BY END USER, 2018-2025 (USD MILLION)
10.2.1 US
10.2.1.1 The US is the largest country-level market for label-free detection
TABLE 98 US: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 99 US: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 100 US: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 101 US: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 102 US: LABEL-FREE DETECTION MARKET, BY END USER, 2018-2025 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Availability of funding for life science research will support market growth
TABLE 103 CANADA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 104 CANADA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 105 CANADA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 106 CANADA: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 107 CANADA: LABEL-FREE DETECTION MARKET, BY END USER, 2018-2025 (USD MILLION)
10.3 EUROPE
TABLE 108 EUROPE: LABEL-FREE DETECTION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 109 EUROPE: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 110 EUROPE: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 111 EUROPE: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 112 EUROPE: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 113 EUROPE: LABEL-FREE DETECTION MARKET, BY END USER, 2018-2025 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany to dominate the European LFD market
TABLE 114 GERMANY: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 115 GERMANY: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 116 GERMANY: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION) 110
TABLE 117 GERMANY: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 118 GERMANY: LABEL-FREE DETECTION MARKET, BY END USER, 2018-2025 (USD MILLION)
10.3.2 UK
10.3.2.1 Government initiatives in academic research to boost the market
TABLE 119 UK: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 120 UK: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 121 UK: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 122 UK: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 123 UK: LABEL-FREE DETECTION MARKET, BY END USER, 2018-2025 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing R&D spending by pharma & life science companies along with government funding to boost the growth of the market
TABLE 124 FRANCE: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 125 FRANCE: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 126 FRANCE: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 127 FRANCE: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 128 FRANCE: LABEL-FREE DETECTION MARKET, BY END USER, 2018-2025 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Increasing focus on drug development to boost the market growth in Italy
TABLE 129 ITALY: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 130 ITALY: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 131 ITALY: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION) 117
TABLE 132 ITALY: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 117
TABLE 133 ITALY: LABEL-FREE DETECTION MARKET, BY END USER, 2018-2025 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing focus on personalized medicines to drive market growth
TABLE 134 SPAIN: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 135 SPAIN: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 136 SPAIN: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 137 SPAIN: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 138 SPAIN: LABEL-FREE DETECTION MARKET, BY END USER, 2018-2025 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 139 ROE: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 140 ROE: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 141 ROE: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 142 ROE: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 143 ROE: LABEL-FREE DETECTION MARKET, BY END USER, 2018-2025 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 15 ASIA PACIFIC: LABEL-FREE DETECTION MARKET SNAPSHOT
TABLE 144 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 145 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 146 ASIA PACIFIC: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 147 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 148 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 149 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY END USER, 2018-2025 (USD MILLION)
10.4.1 CHINA
10.4.1.1 China dominates the APAC market for label-free detection
TABLE 150 CHINA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 151 CHINA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 152 CHINA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 153 CHINA: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 154 CHINA: LABEL-FREE DETECTION MARKET, BY END USER, 2018-2025 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Growing government funding in R&D is the major factor driving the growth of the market in Japan
TABLE 155 JAPAN: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 156 JAPAN: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 157 JAPAN: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 158 JAPAN: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 159 JAPAN: LABEL-FREE DETECTION MARKET, BY END USER, 2018-2025 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Increasing R&D spending by pharmaceutical companies and growing government initiatives in drug discovery are driving the growth of this market
TABLE 160 R&D SPENDING BY TOP INDIAN PHARMACEUTICAL COMPANIES, 2019
TABLE 161 INDIA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 162 INDIA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 163 INDIA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 164 INDIA: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 165 INDIA: LABEL-FREE DETECTION MARKET, BY END USER, 2018-2025 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 166 ROAPAC: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 167 ROAPAC: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 168 ROAPAC: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 169 ROAPAC: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 170 ROAPAC: LABEL-FREE DETECTION MARKET, BY END USER, 2018-2025 (USD MILLION)
10.5 REST OF THE WORLD
TABLE 171 ROW: LABEL-FREE DETECTION MARKET, BY REGION, 2018-2025 (USD MILLION)
TABLE 172 ROW: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 173 ROW: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 174 ROW: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 175 ROW: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 176 ROW: LABEL-FREE DETECTION MARKET, BY END USER, 2018-2025 (USD MILLION)
10.5.1 LATIN AMERICA
10.5.1.1 Rising research activity in the areas of neuroscience, inflammatory diseases, and drug discovery will drive the market in LATAM
TABLE 177 LATAM: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 178 LATAM: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 179 LATAM: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 180 LATAM: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 181 LATAM: LABEL-FREE DETECTION MARKET, BY END USER, 2018-2025 (USD MILLION)
10.5.2 MIDDLE EAST AND AFRICA
10.5.2.1 Increasing focus on tapping the potential of MEA countries indicates prospects for market growth
TABLE 182 MEA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 183 MEA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 184 MEA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 185 MEA: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 186 MEA: LABEL-FREE DETECTION MARKET, BY END USER, 2018-2025 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 142)
11.1 INTRODUCTION
11.2 MARKET RANKING ANALYSIS
FIGURE 16 COMPANY RANKING IN THE LABEL-FREE DETECTION MARKET, 2019
11.3 MARKET EVALUATION FRAMEWORK
TABLE 187 MARKET EVALUATION FRAMEWORK: ACQUISITIONS-THE MAJOR STRATEGY ADOPTED BY PLAYERS
11.4 COMPETITIVE SCENARIO
11.4.1 KEY PRODUCT LAUNCHES
11.4.2 KEY COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS
11.4.3 KEY EXPANSIONS
11.4.4 KEY ACQUISITIONS
12 COMPANY EVALUATION MATRIX AND COMPANY PROFILES (Page No. - 146)
12.1 OVERVIEW
12.2 GLOBAL LABEL-FREE DETECTION MARKET: COMPANY EVALUATION MATRIX
12.2.1 STARS
12.2.2 EMERGING LEADERS
12.2.3 PERVASIVE
12.2.4 EMERGING COMPANIES
FIGURE 17 GLOBAL LABEL-FREE DETECTION MARKET: COMPANY EVALUATION MATRIX, 2019
12.3 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.3.1 DANAHER
FIGURE 18 DANAHER: COMPANY SNAPSHOT
12.3.2 SARTORIUS AG
FIGURE 19 SARTORIUS AG: COMPANY SNAPSHOT
12.3.3 WATERS CORPORATION
FIGURE 20 WATERS: COMPANY SNAPSHOT
12.3.4 PERKINELMER INC.
FIGURE 21 PERKINELMER INC: COMPANY SNAPSHOT
12.3.5 AMETEK, INC.
FIGURE 22 AMETEK, INC.: COMPANY SNAPSHOT
12.3.6 HORIBA, LTD.
FIGURE 23 HORIBA, LTD.: COMPANY SNAPSHOT
12.3.7 SPECTRIS
FIGURE 24 SPECTRIS: COMPANY SNAPSHOT
12.3.8 METTLER TOLEDO
FIGURE 25 METTLER TOLEDO: COMPANY SNAPSHOT
12.3.9 CORNING INCORPORATED
FIGURE 26 CORNING INCORPORATED: COMPANY SNAPSHOT
12.3.10 AGILENT TECHNOLOGIES, INC.
FIGURE 27 AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT
12.3.11 NANOTEMPER TECHNOLOGIES GMBH
12.3.12 SHIMADZU CORPORATION
FIGURE 28 SHIMADZU CORPORATION: COMPANY SNAPSHOT
12.3.13 HITACHI HIGH-TECH CORPORATION
FIGURE 29 HITACHI HIGH-TECH CORPORATION: COMPANY SNAPSHOT
12.3.14 AFFINITÉ INSTRUMENTS
12.3.15 BIOSENSING INSTRUMENT
12.3.16 BIONAVIS LTD.
12.3.17 CREOPTIX AG
12.3.18 NICOYA
12.3.19 BIOPTIX ANALYTICAL LLC
12.3.20 WYATT TECHNOLOGY CORPORATION
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 186)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global label-free detection market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the label-free detection market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
The secondary sources referred to for this research study included publications from government sources, such as World Health Organization, National Center for Biotechnology Information, National Institutes of Health, US Food and Drug Administration, International Molecular Exchange Consortium, Biomolecular Interaction Network Database, Nature (Journal), Genome Medicine, PubMed, European Federation of Pharmaceutical Industries and Associations, European Lead Factory, India Brand Equity Foundation, UK Research Partnership Investment Fund, and Pharmaceutical Research and Manufacturers of America. Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations, among others. Secondary data was collected and analyzed to arrive at the overall size of the global label-free detection market, which was validated through primary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global label-free detection market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as personnel from the pharmaceutical and biotechnology industry) and supply side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, and channel partners, among others) across four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. Approximately 80% and 20% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews
To know about the assumptions considered for the study, download the pdf brochure
Data Triangulation
After arriving at the overall market size, from the market size estimation process explained above, the LFD market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the LFD market.
Report Objectives
- To define, describe, and forecast the label-free detection market on the basis of product and service, technology, application, end user, and region
- To provide detailed information regarding the major factors influencing the market growth, such as drivers, restraints, opportunities, and challenges
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall label-free detection market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the revenue of the market segments with respect to four main regions, namely, North America, Europe, the Asia Pacific (APAC), and the Rest of the World (RoW)
- To profile the key players in the global label-free detection market and comprehensively analyze their core competencies and market rankings
- To track and analyze competitive developments, such as product launches, acquisitions, expansions, and partnerships in the label-free detection market
Available Customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographical Analysis
- Further breakdown of the European label-free detection market into RoE countries.
- Further breakdown of the Asia Pacific label-free detection market into RoAPAC countries.
- Further breakdown of the Rest of the World (RoW) label-free detection market into Brazil, Mexico, Argentina, and the Rest of RoW countries.
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Label-free Detection Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Label-free Detection Market